Raising false hopes and driving people toward unproven cures has happened all too often in the field.
We also pledge to note, as in this case, when the reported results are based on animal and/or tissue studies rather than administration in human subjects.
So with that intro and those caveats, here’s some truly interesting findings recently reported out of Harvard University….
“The active ingredient in marijuana cuts tumor growth in common lung cancer in half and significantly reduces the ability of the cancer to spread, say researchers at Harvard University who tested the chemical in both lab and mouse studies.
They say this is the first set of experiments to show that the compound, Delta-tetrahydrocannabinol (THC), inhibits EGF-induced growth and migration in epidermal growth factor receptor (EGFR) expressing non-small cell lung cancer cell lines. Lung cancers that over-express EGFR are usually highly aggressive and resistant to chemotherapy.
THC that targets cannabinoid receptors CB1 and CB2 is similar in function to endocannabinoids, which are cannabinoids that are naturally produced in the body and activate these receptors. The researchers suggest that THC or other designer agents that activate these receptors might be used in a targeted fashion to treat lung cancer.”
And later in the article:
“Although the researchers do not know why THC inhibits tumor growth, they say the substance could be activating molecules that arrest the cell cycle. They speculate that THC may also interfere with angiogenesis and vascularization, which promotes cancer growth.
Preet says much work is needed to clarify the pathway by which THC functions, and cautions that some animal studies have shown that THC can stimulate some cancers. “THC offers some promise, but we have a long way to go before we know what its potential is,” she said.”
The whole article is recommended reading!
#MMJ #Research #Cancer #LungCancer #UTpol #TRUCE
See full article – Harvard University Finds Cannabis Cuts Tumor Growth in Half in Three Weeks
